0001140361-18-018379.txt : 20180412 0001140361-18-018379.hdr.sgml : 20180412 20180412165232 ACCESSION NUMBER: 0001140361-18-018379 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180412 DATE AS OF CHANGE: 20180412 EFFECTIVENESS DATE: 20180412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310059 FILM NUMBER: 18752550 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 D 1 primary_doc.xml X0708 D LIVE 0001314102 EyePoint Pharmaceuticals, Inc. 480 PLEASANT STREET SUITE B300 WATERTOWN MA MASSACHUSETTS 02472 617-926-5000 DELAWARE None pSivida Corp. pSivida LTD Corporation true Nancy Lurker 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Executive Officer Director President and Chief Executive Officer David Mazzo 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director Chairman of the Board of Directors Michael Rogers 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director Douglas Godshall 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director James Barry 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director Jay Duker 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director Kristine Peterson 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director Leonard S. Ross 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Executive Officer Vice President, Finance and Chief Accounting Officer Dario Paggiarino 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Executive Officer Vice President, Chief Medical Officer Ronald W. Eastman 480 Pleasant Street Suite B300 WATERTOWN MA MASSACHUSETTS 02472 Director Pharmaceuticals Decline to Disclose 06b false 2018-03-28 false true true true false 0 35000000 9466956 25533044 The Company will, subject to stockholder approval, sell approximately $25.5 million of units (each, a "Unit"), with each Unit consisting of (a) one share of Common Stock and (b) one warrant to purchase a share of Common Stock. false 3 0 0 0 false EyePoint Pharmaceuticals, Inc. /s/ Leonard S. Ross Leonard S. Ross Vice President, Finance and Chief Accounting Officer 2018-04-12